Mind Medicine (MNMD) has released an update.
Mind Medicine (MindMed) Inc., a biopharmaceutical company focused on brain health disorders, is set to discuss its financial outcomes for the second quarter of 2024 and provide a corporate update in an upcoming conference call and webcast. This event is scheduled for August 13, 2024, and will be accessible through MindMed’s website with a replay available for 30 days post-event.
For further insights into MNMD stock, check out TipRanks’ Stock Analysis page.
